CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Notre Dame Intermedica Participacoes SA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Notre Dame Intermedica Participacoes SA
Bela Vista
Phone: +55 1131559276p:+55 1131559276 Sao Paulo, 01.311-100  Brazil Fax: +55 1131551766f:+55 1131551766

This company is no longer actively traded on any major stock exchange.

Business Summary
Notre Dame Intermedica Participacoes SA (Notre Dame), formerly known as BCBH Participacoes SA, is a Brazil-based company specialized in the healthcare industry. The Company operates as the holding company of the NotreDame Intermedica Group. Notre Dame has offices in Sao Paulo, Rio de Janeiro, Jundai, Campinas, Sorocaba and Baixada Santista and through its subsidiaries offers different medical services in Brazil. The Company owns more than 15 hospitals, more than 20 emergency rooms, more than 10 units of preventive medicine and more than 65 clinical centers. Notre Dame through its subsidiaries offers health services; dental services, which includes dental plans, preventive dentistry and online contact, and other specialized services as child surgery or occupational health.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202112/31/2020Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board Chris R.Gordon 46 1/1/2019 1/1/2019
Chief Executive Officer, Director IrlauMachado Filho 54 1/1/2019 1/1/2019
Chief Financial Officer Marcelo M.Moreira Filho 51 1/1/2019 1/1/2019
11 additional Officers and Directors records available in full report.

Business Names
Business Name
Ghelfond Medicina Diagnostica
GNDI3
Grupo Samed

General Information
Number of Employees: 11,032 (As of 12/31/2017)
Outstanding Shares: 619,952,440 (As of 1/11/2022)
Stock Exchange: SAO
Fax Number: +55 1131551766


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, November 5, 2024